# IABP In AMI Patients With SCAI-B Study

Study · id `cardio:ct-nct04989777` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04989777](<https://clinicaltrials.gov/study/NCT04989777>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04989777

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 512 participants.

## Technical summary

Registry record NCT04989777. Randomized; single masking; primary purpose treatment. Start 2022-01-01 (anticipated); primary completion 2026-01-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 512 participants (planned count; ClinicalTrials.gov record NCT04989777, source copy `cardio:ctgov-nct04989777-2021-08-13`, retrieved 2026-10-26)
- Planned start: 2022-01-01 (anticipated) (ClinicalTrials.gov record NCT04989777, source copy `cardio:ctgov-nct04989777-2021-08-13`, retrieved 2026-10-26)
- Primary completion: 2026-01-01 (anticipated) (ClinicalTrials.gov record NCT04989777, source copy `cardio:ctgov-nct04989777-2021-08-13`, retrieved 2026-10-26)
- Completion: 2026-01-01 (anticipated) (ClinicalTrials.gov record NCT04989777, source copy `cardio:ctgov-nct04989777-2021-08-13`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04989777, source copy `cardio:ctgov-nct04989777-2021-08-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04989777-2021-08-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: IABP In AMI Patients With SCAI-B Study
- Condition: Myocardial Infarction, Acute
- Condition: Cardiogenic Shock
- Intervention (Device): IABP (Intra-aortic balloon pump ) implantation
- Lead sponsor: Renmin Hospital of Wuhan University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiogenic shock (`cardio:cardiogenic-shock`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Renmin Hospital of Wuhan University (`cardio:org-renmin-hospital-of-wuhan-university`)

## Provenance

Content hash: a141d083d8506f304acbebabe8b52e00f4a74bdeec2d26b5fec020c2c4823f7d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
